• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测COVID-19患者死亡率的血栓炎症特征:FAD-85评分

Thrombo-inflammatory features predicting mortality in patients with COVID-19: The FAD-85 score.

作者信息

Wang Junhong, Zhang Hua, Qiao Rui, Ge Qinggang, Zhang Shuisheng, Zhao Zongxuan, Tian Ci, Ma Qingbian, Shen Ning

机构信息

Emergency Department, Peking University Third Hospital, Beijing, China.

Clinical Epidemiology Research Center, Peking University Third Hospital, Beijing, China.

出版信息

J Int Med Res. 2020 Sep;48(9):300060520955037. doi: 10.1177/0300060520955037.

DOI:10.1177/0300060520955037
PMID:32960106
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7511832/
Abstract

BACKGROUND

The roles of inflammation and hypercoagulation in predicting outcomes of coronavirus disease 2019 (COVID-19) are unclear.

METHODS

Adult patients diagnosed with COVID-19 from 28 January 2020 to 4 March 2020 in Tongji Hospital, Wuhan were recruited. Data on related parameters were collected. Univariate analysis and multivariable binary logistic regression were used to explore predictors of critical illness and mortality.

RESULTS

In total, 199 and 44 patients were enrolled in the training and testing sets, respectively. Elevated ferritin, tumor necrosis factor-α and D-dimer and decreased albumin concentration were associated with disease severity. Older age, elevated ferritin and elevated interleukin-6 were associated with 28-day mortality. The FAD-85 score, defined as age + 0.01 * ferritin +D-dimer, was used to predict risk of mortality. The sensitivity, specificity and accuracy of FAD-85 were 86.4%, 81.8% and 86.4%, respectively. A nomogram was established using age, ferritin and D-dimer to predict the risk of 28-day mortality.

CONCLUSIONS

Thrombo-inflammatory parameters provide key information on the severity and prognosis of COVID-19 and can be used as references for clinical treatment to correct inflammatory and coagulation abnormalities.

摘要

背景

炎症和高凝状态在预测2019冠状病毒病(COVID-19)预后中的作用尚不清楚。

方法

招募了2020年1月28日至2020年3月4日在武汉同济医院被诊断为COVID-19的成年患者。收集相关参数的数据。采用单因素分析和多变量二元逻辑回归来探索危重症和死亡率的预测因素。

结果

分别有199例和44例患者纳入训练集和测试集。铁蛋白、肿瘤坏死因子-α和D-二聚体升高以及白蛋白浓度降低与疾病严重程度相关。年龄较大、铁蛋白升高和白细胞介素-6升高与28天死亡率相关。FAD-85评分定义为年龄+0.01×铁蛋白+D-二聚体,用于预测死亡风险。FAD-85的敏感性、特异性和准确性分别为86.4%、81.8%和86.4%。使用年龄、铁蛋白和D-二聚体建立了列线图来预测28天死亡风险。

结论

血栓炎症参数提供了关于COVID-19严重程度和预后的关键信息,可作为临床治疗纠正炎症和凝血异常的参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cd0/7513402/e1c7ac535aa2/10.1177_0300060520955037-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cd0/7513402/8a43606b7fa3/10.1177_0300060520955037-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cd0/7513402/494b9b03ce44/10.1177_0300060520955037-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cd0/7513402/e1c7ac535aa2/10.1177_0300060520955037-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cd0/7513402/8a43606b7fa3/10.1177_0300060520955037-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cd0/7513402/494b9b03ce44/10.1177_0300060520955037-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cd0/7513402/e1c7ac535aa2/10.1177_0300060520955037-fig3.jpg

相似文献

1
Thrombo-inflammatory features predicting mortality in patients with COVID-19: The FAD-85 score.预测COVID-19患者死亡率的血栓炎症特征:FAD-85评分
J Int Med Res. 2020 Sep;48(9):300060520955037. doi: 10.1177/0300060520955037.
2
COVID-19 coagulopathy: An in-depth analysis of the coagulation system.COVID-19 凝血功能障碍:对凝血系统的深入分析。
Eur J Haematol. 2020 Dec;105(6):741-750. doi: 10.1111/ejh.13501. Epub 2020 Aug 19.
3
IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19.IP-10 和 MCP-1 作为与 COVID-19 疾病严重程度相关的生物标志物。
Mol Med. 2020 Oct 29;26(1):97. doi: 10.1186/s10020-020-00230-x.
4
IL-6-based mortality risk model for hospitalized patients with COVID-19.基于 IL-6 的 COVID-19 住院患者死亡风险模型。
J Allergy Clin Immunol. 2020 Oct;146(4):799-807.e9. doi: 10.1016/j.jaci.2020.07.009. Epub 2020 Jul 22.
5
COVID-19 and SIC (!).2019冠状病毒病与噬血细胞性淋巴组织细胞增生症(!)
J Vasc Surg. 2020 Sep;72(3):1148-1150. doi: 10.1016/j.jvs.2020.05.047. Epub 2020 Jun 1.
6
Diagnostic performance of initial blood urea nitrogen combined with D-dimer levels for predicting in-hospital mortality in COVID-19 patients.初始血尿素氮联合 D-二聚体水平对预测 COVID-19 患者住院死亡率的诊断性能。
Int J Antimicrob Agents. 2020 Sep;56(3):106110. doi: 10.1016/j.ijantimicag.2020.106110. Epub 2020 Jul 23.
7
COVID-19 and Hypercoagulability.新型冠状病毒肺炎与高凝状态
Clin Adv Hematol Oncol. 2020 Jul;18(7):386-389.
8
D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19.入院时 D-二聚体水平预测 COVID-19 患者住院死亡率。
J Thromb Haemost. 2020 Jun;18(6):1324-1329. doi: 10.1111/jth.14859.
9
Coagulopathy in COVID-19: Focus on vascular thrombotic events.新型冠状病毒肺炎相关凝血功能障碍:关注血管血栓栓塞事件。
J Mol Cell Cardiol. 2020 Sep;146:32-40. doi: 10.1016/j.yjmcc.2020.07.003. Epub 2020 Jul 15.
10
Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study.新冠病毒肺炎分类及预后评估中的血液学特征与危险因素:一项回顾性队列研究
Lancet Haematol. 2020 Sep;7(9):e671-e678. doi: 10.1016/S2352-3026(20)30217-9. Epub 2020 Jul 10.

引用本文的文献

1
The association between mortality due to COVID-19 and coagulative parameters: a systematic review and meta-analysis study.2019冠状病毒病所致死亡与凝血参数之间的关联:一项系统评价和荟萃分析研究
BMC Infect Dis. 2024 Dec 2;24(1):1373. doi: 10.1186/s12879-024-10229-y.
2
Predicting In-Hospital Mortality in Severe COVID-19: A Systematic Review and External Validation of Clinical Prediction Rules.预测重症 COVID-19 的院内死亡率:临床预测规则的系统评价与外部验证
Biomedicines. 2022 Sep 27;10(10):2414. doi: 10.3390/biomedicines10102414.
3
Diagnostic Accuracy of Liquid Biomarkers in Airway Diseases: Toward Point-of-Care Applications.

本文引用的文献

1
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020.2019新型冠状病毒病(COVID-19)疫情的流行病学特征 - 中国,2020年
China CDC Wkly. 2020 Feb 21;2(8):113-122.
2
Protocol for Prevention and Control of COVID-19 (Edition 6).新型冠状病毒肺炎防控方案(第六版)
China CDC Wkly. 2020 May 8;2(19):321-326. doi: 10.46234/ccdcw2020.082.
3
Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients.肺泡巨噬细胞功能障碍和细胞因子风暴在两例严重 COVID-19 患者发病机制中的作用。
气道疾病中液体生物标志物的诊断准确性:迈向即时护理应用
Front Med (Lausanne). 2022 Jun 6;9:855250. doi: 10.3389/fmed.2022.855250. eCollection 2022.
4
Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis.研究2019冠状病毒病重症和死亡风险因素的研究中的异质性和偏倚风险:一项系统评价和荟萃分析
Pathogens. 2022 May 10;11(5):563. doi: 10.3390/pathogens11050563.
5
Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis.严重和致命 COVID-19 感染患者免疫功能障碍的代表性参数的识别:系统评价和荟萃分析。
Clin Rev Allergy Immunol. 2023 Feb;64(1):33-65. doi: 10.1007/s12016-021-08908-8. Epub 2022 Jan 18.
6
Hemostatic System (Fibrinogen Level, D-Dimer, and FDP) in Severe and Non-Severe Patients With COVID-19: A Systematic Review and Meta-Analysis.严重和非严重 COVID-19 患者的止血系统(纤维蛋白原水平、D-二聚体和纤维蛋白降解产物):系统评价和荟萃分析。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211010973. doi: 10.1177/10760296211010973.
7
Rapid Evaluation of Coronavirus Illness Severity (RECOILS) in intensive care: Development and validation of a prognostic tool for in-hospital mortality.重症监护中冠状病毒疾病严重程度的快速评估(RECOILS):院内死亡率预测工具的开发和验证。
Acta Anaesthesiol Scand. 2022 Jan;66(1):65-75. doi: 10.1111/aas.13991. Epub 2021 Oct 15.
8
Thrombotic and Hypercoagulability Complications of COVID-19: An Update.新型冠状病毒肺炎的血栓形成与高凝并发症:最新进展
J Blood Med. 2021 Aug 31;12:785-793. doi: 10.2147/JBM.S316014. eCollection 2021.
9
High-dose intravenous immunoglobulins as a therapeutic option in critical illness polyneuropathy accompanying SARS-CoV-2 infection: A case-based review of the literature (Review).大剂量静脉注射免疫球蛋白作为新型冠状病毒肺炎伴发危重病性多发性神经病的一种治疗选择:基于病例的文献综述(综述)
Exp Ther Med. 2021 Oct;22(4):1182. doi: 10.3892/etm.2021.10616. Epub 2021 Aug 16.
10
ABC-SPH risk score for in-hospital mortality in COVID-19 patients: development, external validation and comparison with other available scores.COVID-19患者院内死亡的ABC-SPH风险评分:开发、外部验证及与其他现有评分的比较
Int J Infect Dis. 2021 Sep;110:281-308. doi: 10.1016/j.ijid.2021.07.049. Epub 2021 Jul 24.
EBioMedicine. 2020 Jul;57:102833. doi: 10.1016/j.ebiom.2020.102833. Epub 2020 Jun 20.
4
Considering how biological sex impacts immune responses and COVID-19 outcomes.考虑到生物性别如何影响免疫反应和 COVID-19 的结果。
Nat Rev Immunol. 2020 Jul;20(7):442-447. doi: 10.1038/s41577-020-0348-8. Epub 2020 Jun 11.
5
Gendered effects on inflammation reaction and outcome of COVID-19 patients in Wuhan.武汉 COVID-19 患者炎症反应和结局的性别影响。
J Med Virol. 2020 Nov;92(11):2684-2692. doi: 10.1002/jmv.26137. Epub 2020 Jun 19.
6
Impact of sex and gender on COVID-19 outcomes in Europe.欧洲 COVID-19 结局的性别差异。
Biol Sex Differ. 2020 May 25;11(1):29. doi: 10.1186/s13293-020-00304-9.
7
Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.关于 SARS-CoV-2 感染潜在发病机制的假说——病毒性肺炎患者免疫变化的综述。
Emerg Microbes Infect. 2020 Dec;9(1):727-732. doi: 10.1080/22221751.2020.1746199.
8
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
9
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
10
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病(COVID-19)患者免疫反应失调。
Clin Infect Dis. 2020 Jul 28;71(15):762-768. doi: 10.1093/cid/ciaa248.